Evidence map›Paper›PMID 19949965›Full record

ReviewModern rheumatology2010

Adenosine in fibrosis.

Edwin S L Chan, Bruce N Cronstein

Open access · greenAbstract readReview
In one paragraph

Review in Modern rheumatology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Targeting GPCRs to treat cardiac fibrosis.Frontiers in cardiovascular medicine · 2022
    Review
  7. Review
  8. Review
  9. Role of Cardiac AFrontiers in pharmacology · 2020
    Review
  10. Review
  11. The Antifibrotic Effect of AArthritis & rheumatology (Hoboken, N.J.) · 2018
    Article
  12. Article
  13. Review
  14. Purinergic Signalling: Therapeutic Developments.Frontiers in pharmacology · 2017
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Edwin S L ChanClinical and Translational Science Institute, NYU School of Medicine, 550 First Ave., New York, NY 10016, USA.
Bruce N Cronstein
New York University · US

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR029893 · NCRR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2009 to 2011
$17.7M
The Pharmacology of Dermal Fibrosis R01AR056672 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2009 to 2018
$4.6M
Purinergic Regulation of Bone MetabolismR01AR054897 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2008 to 2014
$2.1M
The Pharmacology of Dermal FibrosisR56AR056672 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2014 to 2014
$373k
NCRR NIH HHS UL1 RR029893NCRR NIH HHS UL1RR029893NIAMS NIH HHS AR54897NIAMS NIH HHS AR56672NIAMS NIH HHS R01 AR054897NIAMS NIH HHS R01 AR056672NIAMS NIH HHS R56 AR056672
6 · The paper itself

Abstract

Adenosine is an endogenous autocoid that regulates a multitude of bodily functions. Its anti-inflammatory actions are well known to rheumatologists since it mediates many of the anti-inflammatory effects of a number of antirheumatic drugs such as methotrexate. However, inflammatory and tissue regenerative responses are intricately linked, with wound healing being a prime example. It has only recently been appreciated that adenosine has a key role in tissue regenerative and fibrotic processes. An understanding of these processes may shed new light on potential therapeutic options in diseases such as scleroderma where tissue fibrosis features prominently.

Indexed as

AdenosineAnimalsFibrosisHumansMicePurinergic P1 Receptor AgonistsReceptors, Purinergic P1Signal TransductionWound HealingAdenosinePurinergic P1 Receptor AgonistsReceptors, Purinergic P1

Identifiers

PMID19949965
PMCPMC3129242
OpenAlexW2122099472

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.